Skip Navigation

watchlive

Pre-Markets
U.S. Markets
Currencies
Cryptocurrency
Futures & Commodities
Bonds
Funds & ETFs

Economy
Finance
Health & Science
Media
Real Estate
Energy
Climate
Transportation
Industrials
Retail
Wealth
Sports
Life
Small Business

Personal Finance
Fintech
Financial Advisors
Options Action
ETF Street
Buffett Archive
Earnings
Trader Talk

Cybersecurity
Enterprise
Internet
Media
Mobile
Social Media
CNBC Disruptor 50
Tech Guide

White House
Policy
Defense
Congress
Equity and Opportunity

Live TV
Live Audio
Business Day Shows
Entertainment Shows
Full Episodes
Latest Video
Top Video
CEO Interviews
CNBC Documentaries
CNBC Podcasts
CNBC World
Digital Originals
Live TV Schedule

Trust Portfolio
Analysis
Trade Alerts
Meeting Videos
Homestretch
Jim's Columns
Education
Subscribe
Sign In

Pro News
Pro Live
Full Episodes
Stock Screener
Market Forecast
Options Investing
Chart Investing
Subscribe
Sign In

Make It

USA
INTL

watchlive

Here are Jim Cramer's rapid-fire takes on 5 stocks in the news Monday

Published Mon, Feb 5 202412:53 PM EST

Paulina Likos @paulina_likos

Catalent – Shares were up nearly 10% after the parent of Danish drugmaker Novo Nordisk announced a $16.5 billion acquisition. The deal for Catalent, which helps drug companies develop and deliver their products, aims to boost the supply of Novo's GLP-1s: weight loss drug Wegovy and diabetes treatment Ozempic. Jim Cramer said this deal is Novo's way to "get more product" and addresses the "tremendous shortage" of these high-demand drugs. Shares of Eli Lilly , a stock in the CNBC Investing Club 's portfolio, were also up more than 4% ahead of Tuesday's earnings. Lilly makes competing GLP-1s Zepound for weight loss and Mounjaro for diabetes. Snap – The social media firm laid off 10% of its workforce ahead of Tuesday's earnings. Cramer said the move has more to do with saving on cost rather than an impact on its sales. Other tech giants like Club names Meta Platforms , Microsoft and Alphabet also cut its headcount at the start of the year. Cigna – The managed care provider caught two upgrades Monday: RBC Capital and Cantor Fitzgerald. We got out of rival Humana , which was doing poorly. McDonald's – The fast food giant delivered a nice beat on earnings Monday but sales missed — impacted by sales in the Middle East and elsewhere due to boycotts over the Israel-Hamas war. Jim pointed out that Club name Starbucks (SBUX) has also been experiencing the same thing. Jim said buy McDonald's stock on weakness. Mattel – Shares of the toymaker fell more than 2% on Monday after JPMorgan issued a downgrade on expectations of weak sales. Jim wonders whether the issue could be existential: "Are hard toys going to remain something important in the era of the Vision Pro and other incredible devices" from Club name Apple and other companies?

Subscribe to CNBC PRO
Subscribe to Investing Club
Licensing & Reprints
CNBC Councils
Select Personal Finance
CNBC on Peacock
Join the CNBC Panel
Supply Chain Values
Select Shopping
Closed Captioning
Digital Products
News Releases
Internships
Corrections
About CNBC
Ad Choices
Site Map
Podcasts
Careers
Help
Contact

News Tips
Got a confidential news tip? We want to hear from you.
Get In Touch
CNBC Newsletters
Sign up for free newsletters and get more CNBC delivered to your inbox
Sign Up Now
Get this delivered to your inbox, and more info about our products and services.
Advertise With Us
Please Contact Us

Privacy Policy
CA Notice
Terms of Service

© 2024 CNBC LLC. All Rights Reserved. A Division of NBCUniversal

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided by